0.68 - 0.75
0.33 - 0.86
12.80M / 4.66M (Avg.)
35.00 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
39.61%
Revenue growth similar to 0819.HK's 39.55%. Walter Schloss would see if both companies share industry tailwinds.
17.91%
Gross profit growth under 50% of 0819.HK's 36.53%. Michael Burry would be concerned about a severe competitive disadvantage.
66.33%
EBIT growth above 1.5x 0819.HK's 35.70%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
66.33%
Operating income growth above 1.5x 0819.HK's 35.70%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
-47.50%
Negative net income growth while 0819.HK stands at 31.58%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-11.19%
Negative EPS growth while 0819.HK is at 34.09%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-47.67%
Negative diluted EPS growth while 0819.HK is at 34.09%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-40.81%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
33.34%
Positive OCF growth while 0819.HK is negative. John Neff would see this as a clear operational advantage vs. the competitor.
22.09%
Positive FCF growth while 0819.HK is negative. John Neff would see a strong competitive edge in net cash generation.
30.51%
10Y revenue/share CAGR under 50% of 0819.HK's 1259.78%. Michael Burry would suspect a lasting competitive disadvantage.
-1.91%
Negative 5Y CAGR while 0819.HK stands at 153.46%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
16.37%
3Y revenue/share CAGR under 50% of 0819.HK's 93.99%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
-267.39%
Negative 10Y OCF/share CAGR while 0819.HK stands at 186.60%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-307.51%
Negative 5Y OCF/share CAGR while 0819.HK is at 75.56%. Joel Greenblatt would question the firm’s operational model or cost structure.
34.33%
3Y OCF/share CAGR above 1.5x 0819.HK's 5.00%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
135.80%
Below 50% of 0819.HK's 400.59%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
97.13%
Below 50% of 0819.HK's 1147.19%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-59.63%
Negative 3Y CAGR while 0819.HK is 94.45%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
418.24%
10Y equity/share CAGR above 1.5x 0819.HK's 261.50%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
52.20%
5Y equity/share CAGR at 75-90% of 0819.HK's 65.62%. Bill Ackman might push for an improved ROE or share repurchase strategy to keep up.
23.32%
Below 50% of 0819.HK's 49.53%. Michael Burry suspects a serious short-term disadvantage in building book value.
-100.00%
Cut dividends over 10 years while 0819.HK stands at 196.59%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.76%
Our AR growth while 0819.HK is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
-3.93%
Inventory is declining while 0819.HK stands at 13.03%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
5.51%
Asset growth 1.25-1.5x 0819.HK's 4.43%. Bruce Berkowitz sees if the firm's investments effectively outpace the competitor in future returns.
69.47%
BV/share growth above 1.5x 0819.HK's 5.15%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-22.54%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
97.36%
R&D growth drastically higher vs. 0819.HK's 46.04%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
9.83%
SG&A declining or stable vs. 0819.HK's 38.39%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.